However, it is also possible that the problem is related to. Studies show that too much Botox per session or a high cumulative dose over years of treatment can cause immunity to Botox. To reduce the risk of developing immunity to Botox due to too much Botox, ask your healthcare provider to give you the lowest dose of Botox for maximum effect. In addition, separate treatments as long as possible (based on your healthcare provider's recommendations)).
The answer is yes, but almost never in aesthetic patients. Antibodies against Botox are rare (between 1 and 2%) and are almost always seen in people who receive very high doses to treat diseases such as dystonia, muscle spasticity and urological conditions. What is this interval? Some say that injections should be done at a maximum interval of 2 weeks and others say that they can be done at any interval because the formation of antibodies would be a myth. To avoid the formation of neutralizing antibodies, which would make the injections ineffective, it is essential to follow a treatment program that reflects the rate at which the body metabolizes the chosen injection (once again, every three to six months on average)).
Researchers use different functional, serological and experimental tests in clinical settings to confirm the presence of Botox antibodies, but there are no commercially available tests yet. On the contrary, there are many nuances surrounding neurotoxin injections that you need to consider before you start to worry that, over time, immunity will develop against them. This case suggests that the introduction of foreign proteins through the vaccine (which aims to help the body generate an immune response against the virus) may have caused the formation of neutralizing antibodies. He spoke of the fact that neutralizing antibodies were not always related to the lack of response to Botox (that is, some of those with antibodies, Botox still worked).).
The first thing she recommends is taking a “break” from neurotoxin injections to allow the body to eliminate on its own any neutralizing antibodies it may have developed. After the injection, the antibodies adhere to the molecule before it has a chance to act on the nerve and block nerve signals that reach the target muscle. Antibody formation can occur in response to botulinum toxin, which is the active ingredient in the formula, or to the supporting proteins contained in the formula, adds Dr. There are limited studies and anecdotal data that suggest the following risk factors for the formation of neutralizing antibodies against botulinum toxin type A.
Resistance to BOTOX is a situation in which a patient has accumulated antibodies against botulinum toxin or metabolizes the drug BOTOX with exceptional speed. Botox resistance or immunity to botox occurs when the patient's immune system develops antibodies that neutralize the active molecule of the injectable, the botulinum toxin type A.
